A study led by the University of Warwick has found a link between the removal of ovaries during hysterectomy and an increase in heart disease, cancer and premature death.
Researchers at the University of Southampton have developed a new 3D system to study human infection in the laboratory. The team, which includes infection researchers, engineers and bioinformaticians in Southampton and at University College London, have used an electrostatic encapsulation technique to make tiny 3D spheres within which human cells are infected with tuberculosis (TB) bacteria to generate conditions that more closely reflect events in patients.
UK biotech company Nemaura Pharma has announced a commitment from private investors of up to £5m for the development of a hormone Biologic using its Micro-Patch™ solid dose delivery platform. The fast-growing company has made significant progress in the reformulation of liquid vaccines administered through the skin using its solid dose delivery system. The funding is being used to accelerate Nemaura’s commercial research and development of clinical programmes to prepare the drug-device combination for market.
Arbutus Biopharma Corporation an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus (HBV) infection, announced that the Supreme Court of British Columbia granted Arbutus’ request for a pre-trial injunction against Acuitas, preventing Acuitas from sublicensing Arbutus’ lipid nanoparticle (LNP) technology until the end of October, or further order of the Court. Under the terms of the pre-trial injunction, Acuitas is prevented from entering into any new agreements which include sublicensing of Arbutus’ LNP.
India spends about 1 percent of its gross domestic product (GDP) on public health, compared to 3 percent in China and 8.3 percent in the United States. Despite this low budget allotment, the contribution has been decreasing or kept stagnant in India since several years.
Investments and innovations in R & D activities are pushing market players to launch manufacturing projects in environmentally friendly and biodegradable packaging, which are expected to increase in the near future . In addition, the expiration of patents for various drug drugs should feed the pharmaceutical packaging market during the forecast period.
New research estimates that Global counterfeiting and piracy will continue to grow at a shocking rate over the next five years, hitting a level of $1.9trn to $2.8trn by 2022.
The report builds on findings of an often-cited Organization for Economic Cooperation and Development (OECD) and European Union Intellectual Property Office (EUIPO) report, which estimated that trade in counterfeit and pirated products accounted for as much as 2.5 per cent of global trade in 2013.
President Trump promised to review the Food and Drug Administration could make major changes, including steps to accelerate the approval process of new prescription drugs, setting up a shock with critics who say its push for the Deregulation could put consumers at risk.
In response to a written question in Rajya Sabha, Minister of State for Health Faggan Singh Kulaste stated that a subcommittee formed to consider issues related to online drug sales presented its recommendations suggesting the creation of a national portal to monitor such sales as well as certain restrictions imposed on them.
The capitalization of export opportunities in regulated and semi-regulated markets was the way forward for the Indian pharmaceutical sector. The government's ease of driving policy should benefit several Indian drug manufacturers.